Search | VHL Search Portal

1.

Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity.

Zhang, Yuankun; Song, Qingxiao; Cassady, Kaniel; Lee, Michael; Tang, Haidong; Zheng, Moqian; Wang, Bixin; Schones, Dustin E; Fu, Yang-Xin; Riggs, Arthur D; Martin, Paul J; Feng, Ru; Zeng, Defu.

Proc Natl Acad Sci U S A ; 120(16): e2205085120, 2023 04 18.

Article in English | MEDLINE | ID: mdl-37036990

2.

Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.

Kong, Xiaohui; Wu, Xiwei; Wang, Bixin; Zeng, Deye; Cassady, Kaniel; Nasri, Ubaydah; Zheng, Moqian; Wu, Alyssa; Qin, Hanjun; Tsai, Weimin; Salhotra, Amandeep; Nakamura, Ryotaro; Martin, Paul J; Zeng, Defu.

Blood ; 140(25): 2740-2753, 2022 12 22.

Article in English | MEDLINE | ID: mdl-36084473

3.

Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.

Casto, Amanda M; Seo, Sachiko; Levine, David M; Storer, Barry E; Dong, Xinyuan; Hansen, John A; Boeckh, Michael; Martin, Paul J.

Blood ; 138(17): 1628-1636, 2021 10 28.

Article in English | MEDLINE | ID: mdl-34269803

4.

Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.

Song, Qingxiao; Wang, Xiaoning; Wu, Xiwei; Qin, Hanjun; Li, Yingfei; Riggs, Arthur D; Martin, Paul J; Chen, Yuan-Zhong; Zeng, Defu.

Blood ; 137(16): 2243-2255, 2021 04 22.

Article in English | MEDLINE | ID: mdl-33511398

5.

Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease.

Chen, George L; Onstad, Lynn; Martin, Paul J; Carpenter, Paul; Pidala, Joseph; Arai, Sally; Cutler, Corey; Hamilton, Betty K; Lee, Stephanie J; Arora, Mukta.

Haematologica ; 108(2): 483-489, 2023 02 01.

Article in English | MEDLINE | ID: mdl-35615925

6.

How I treat steroid-refractory acute graft-versus-host disease.

Martin, Paul J.

Blood ; 135(19): 1630-1638, 2020 05 07.

Article in English | MEDLINE | ID: mdl-32202630

7.

CD24Fc to DAMPen GVHD.

Martin, Paul J.

Blood ; 143(1): 1-2, 2024 01 04.

Article in English | MEDLINE | ID: mdl-38175676

8.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.

Cooper, Jason P; Storer, Barry E; Granot, Noa; Gyurkocza, Boglark; Sorror, Mohamed L; Chauncey, Thomas R; Shizuru, Judith; Franke, Georg-Nikolaus; Maris, Michael B; Boyer, Michael; Bruno, Benedetto; Sahebi, Firoozeh; Langston, Amelia A; Hari, Parameswaran; Agura, Edward D; Lykke Petersen, Søren; Maziarz, Richard T; Bethge, Wolfgang; Asch, Julie; Gutman, Jonathan A; Olesen, Gitte; Yeager, Andrew M; Hübel, Kai; Hogan, William J; Maloney, David G; Mielcarek, Marco; Martin, Paul J; Flowers, Mary E D; Georges, George E; Woolfrey, Ann E; Deeg, Joachim H; Scott, Bart L; McDonald, George B; Storb, Rainer; Sandmaier, Brenda M.

Haematologica ; 106(6): 1599-1607, 2021 06 01.

Article in English | MEDLINE | ID: mdl-32499241

9.

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.

McDonald, George B; Sandmaier, Brenda M; Mielcarek, Marco; Sorror, Mohamed; Pergam, Steven A; Cheng, Guang-Shing; Hingorani, Sangeeta; Boeckh, Michael; Flowers, Mary D; Lee, Stephanie J; Appelbaum, Frederick R; Storb, Rainer; Martin, Paul J; Deeg, H Joachim; Schoch, Gary; Gooley, Ted A.

Ann Intern Med ; 172(4): 229-239, 2020 02 18.

Article in English | MEDLINE | ID: mdl-31958813

10.

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.

Kebriaei, Partow; Hayes, Jack; Daly, Andrew; Uberti, Joseph; Marks, David I; Soiffer, Robert; Waller, Edmund K; Burke, Elizabeth; Skerrett, Donna; Shpall, Elizabeth; Martin, Paul J.

Biol Blood Marrow Transplant ; 26(5): 835-844, 2020 05.

Article in English | MEDLINE | ID: mdl-31505228

11.

Disability Related to Chronic Graft-versus-Host Disease.

Hamilton, Betty K; Storer, Barry E; Wood, William A; Pidala, Joseph A; Cutler, Corey S; Martin, Paul J; Chen, George; Flowers, Mary E; Lee, Stephanie J.

Biol Blood Marrow Transplant ; 26(4): 772-777, 2020 04.

Article in English | MEDLINE | ID: mdl-31669175

12.

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche.

Koyama, Motoko; Samson, Luke; Ensbey, Kathleen S; Takahashi, Shuichiro; Clouston, Andrew D; Martin, Paul J; Hill, Geoffrey R.

Blood ; 141(3): 315-319, 2023 01 19.

Article in English | MEDLINE | ID: mdl-36201741

13.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

Rozmus, Jacob; Kariminia, Amina; Abdossamadi, Sayeh; Storer, Barry E; Martin, Paul J; Lee, Stephanie J; Wolff, Daniel; Arora, Mukta; Cutler, Corey; Schultz, Kirk R.

Biol Blood Marrow Transplant ; 25(3): 451-458, 2019 03.

Article in English | MEDLINE | ID: mdl-30447393

14.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

Martin, Paul J; Storer, Barry E; Palmer, Jeanne; Jagasia, Madan H; Chen, George L; Broady, Raewyn; Arora, Mukta; Pidala, Joseph A; Hamilton, Betty K; Lee, Stephanie J.

Biol Blood Marrow Transplant ; 25(9): 1869-1874, 2019 09.

Article in English | MEDLINE | ID: mdl-31085305

15.

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.

Pidala, Joseph A; Hamilton, Betty K; Martin, Paul J; Onstad, Lynn; Storer, Barry E; Palmer, Jeanne; Alousi, Amin; Cutler, Corey; Jagasia, Madan H; Chen, George L; Arora, Mukta; Flowers, Mary E; Lee, Stephanie J.

Biol Blood Marrow Transplant ; 25(12): 2468-2473, 2019 12.

Article in English | MEDLINE | ID: mdl-31394265

16.

Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.

McCune, Jeannine S; Wang, Tao; Bo-Subait, Khalid; Aljurf, Mahmoud; Beitinjaneh, Amer; Bubalo, Joseph; Cahn, Jean-Yves; Cerny, Jan; Chhabra, Saurabh; Cumpston, Aaron; Dupuis, L Lee; Lazarus, Hillard M; Marks, David I; Maziarz, Richard T; Norkin, Maxim; Prestidge, Tim; Mineishi, Shin; Krem, Maxwell M; Pasquini, Marcelo; Martin, Paul J.

Biol Blood Marrow Transplant ; 25(7): 1424-1431, 2019 07.

Article in English | MEDLINE | ID: mdl-30871976

17.

Sitagliptin to Prevent Acute Graft-versus-Host Disease.

Martin, Paul J.

N Engl J Med ; 384(1): 70-71, 2021 01 07.

Article in English | MEDLINE | ID: mdl-33406333

18.

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Martin, Paul J; Levine, David M; Storer, Barry E; Warren, Edus H; Zheng, Xiuwen; Nelson, Sarah C; Smith, Anajane G; Mortensen, Bo K; Hansen, John A.

Blood ; 129(6): 791-798, 2017 02 09.

Article in English | MEDLINE | ID: mdl-27872059

19.

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

Fisher, Cynthia E; Hohl, Tobias M; Fan, Wenhong; Storer, Barry E; Levine, David M; Zhao, Lu Ping; Martin, Paul J; Warren, Edus H; Boeckh, Michael; Hansen, John A.

Blood ; 129(19): 2693-2701, 2017 05 11.

Article in English | MEDLINE | ID: mdl-28270451

20.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

Martin, Paul J; Storer, Barry E; Inamoto, Yoshihiro; Flowers, Mary E D; Carpenter, Paul A; Pidala, Joseph; Palmer, Jeanne; Arora, Mukta; Jagasia, Madan; Arai, Sally; Cutler, Corey S; Lee, Stephanie J.

Blood ; 130(3): 360-367, 2017 07 20.

Article in English | MEDLINE | ID: mdl-28495794

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity.

Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.

Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.

Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.

Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease.

How I treat steroid-refractory acute graft-versus-host disease.

CD24Fc to DAMPen GVHD.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.

Disability Related to Chronic Graft-versus-Host Disease.

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.

Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.

Sitagliptin to Prevent Acute Graft-versus-Host Disease.

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.